Capricor Therapeutics (CAPR) Debt Ratio (2010 - 2024)

Capricor Therapeutics' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.04 for Q3 2024.

• In Q3 2024, Debt Ratio fell 60.03% year-over-year to 0.04; the TTM figure through Sep 2024 stood at 0.04 (down 60.03% YoY), while the FY2023 annual figure was 0.06, down 16.91% from the prior year.
• Debt Ratio was 0.04 for Q3 2024 at Capricor Therapeutics, down from 0.09 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.24 in Q1 2020 to a low of 0.0 in Q2 2020.
• Historically, Debt Ratio has averaged 0.08 across 5 years, with a median of 0.07 in 2022.
• The sharpest annual moves came in 2020 and 2021: Debt Ratio slumped 98.96% in 2020, then jumped 1661.27% in 2021.
• A 5-year view of Debt Ratio shows it stood at 0.1 in 2020, then fell by 1.37% to 0.1 in 2021, then retreated by 28.08% to 0.07 in 2022, then retreated by 16.91% to 0.06 in 2023, then slumped by 36.81% to 0.04 in 2024.
• The last three Debt Ratio figures came in at 0.04 (Q3 2024), 0.09 (Q2 2024), and 0.07 (Q1 2024), per Business Quant data.